Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles

Detalhes bibliográficos
Autor(a) principal: Foladori, Guillermo
Data de Publicação: 2019
Outros Autores: Invernizzi, Noela
Tipo de documento: Artigo
Idioma: spa
eng
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1257
Resumo: Introduction: The regulation of chemical substances involves a difficult negotiation between social actors, and requires the articulation between scientific analysis and its conversion into a legal norm. Objective: The article addresses the discussion elicited by a public consultation on a voluntary regulation guide on silver nanoparticles (AgNP) in workplaces. It examines the comments made from 2016 to 2018 by diverse social actors – business representatives, non-governmental organizations (NGO) and independent researchers – to two successive draft versions of a Recommended Exposure Limit (REL) in working environments with AgNP. The REL is a voluntary guideline on permissible exposure limits elaborated by the NIOSH in the United States. A guideline of this kind combines scientific information with its legal adjustment. Method: The methodology used was a content analysis of the comments, structured upon a historical and sociotechnical contextualization of nanotechnologies carried out through literature review and documental analysis. Results: The article shows how different social actors position themselves in the controversy over the risks of nanosilver, revealing a pattern of behavior consistent with their position in the research, production and commercialization of this new nanomaterial. While a group of actors, aligned with the interests of AgNP producers, proposed the restriction of mandatory and AgNP-specific regulation, another group of moreheterogeneous actors, identified with the interests of workers and consumers, demanded for more scientific and technical information and stricter health protection measures. Conclusions: Within these divergent stands, the regulatory agency behaved in a transparent and receptive manner while conducting the public consultation and substantively modified the originally proposed exposure limits to AgNP.
id FIOCRUZ-9_19a803bfbcb4b77614dabca61db00f66
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/1257
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticlesPerspectivas e intereses en la construcción de normas de salud ocupacional: el caso de las nanopartículas de plataNanosilverRisksRecommended Exposure LimitsRegulationOccupational SafetynanopratariscosRELregulaçãosegurança ocupacionalIntroduction: The regulation of chemical substances involves a difficult negotiation between social actors, and requires the articulation between scientific analysis and its conversion into a legal norm. Objective: The article addresses the discussion elicited by a public consultation on a voluntary regulation guide on silver nanoparticles (AgNP) in workplaces. It examines the comments made from 2016 to 2018 by diverse social actors – business representatives, non-governmental organizations (NGO) and independent researchers – to two successive draft versions of a Recommended Exposure Limit (REL) in working environments with AgNP. The REL is a voluntary guideline on permissible exposure limits elaborated by the NIOSH in the United States. A guideline of this kind combines scientific information with its legal adjustment. Method: The methodology used was a content analysis of the comments, structured upon a historical and sociotechnical contextualization of nanotechnologies carried out through literature review and documental analysis. Results: The article shows how different social actors position themselves in the controversy over the risks of nanosilver, revealing a pattern of behavior consistent with their position in the research, production and commercialization of this new nanomaterial. While a group of actors, aligned with the interests of AgNP producers, proposed the restriction of mandatory and AgNP-specific regulation, another group of moreheterogeneous actors, identified with the interests of workers and consumers, demanded for more scientific and technical information and stricter health protection measures. Conclusions: Within these divergent stands, the regulatory agency behaved in a transparent and receptive manner while conducting the public consultation and substantively modified the originally proposed exposure limits to AgNP.Introducción: La regulación de substancias químicas envuelve una difícil negociación entre actores sociales, y requiere de la articulación entre el análisis científico y su conversión en norma jurídica. Objetivo: El artículo aborda la discusión suscitada por la consulta pública sobre una propuesta de guía voluntaria de regulación de nanopartículas de plata (AgNP) en locales de trabajo en los Estados Unidos. Se examinan los comentarios realizados entre 2016 y 2018 por diversos actores sociales – representantes de empresas, organizaciones no gubernamentales (ONG) e investigadores independientes – a dos versiones sucesivas de borrador de Recommended Exposure Limit (REL) en ambientes de trabajo con AgNP. Se trata de una guía voluntaria delímites de exposición permisibles elaborada por el NIOSH de los Estados Unidos. Una guía de esta naturaleza combina información científica con su ajuste jurídico. Método: La metodología utilizada fue un análisis de contenido de los comentarios, estructurado a partir de la contextualización histórica y sociotécnica de las nanotecnologías realizada mediante revisión de literatura y análisis documental. Resultados: El artículo muestra la manera como los diferentes actores sociales se situaron en la controversia sobre los riesgos de la nanoplata, develando un patrón de comportamiento que es acorde con la posición que tienen en el proceso de investigación, producción y comercialización de este nuevo nanomaterial. Mientras un conjunto de actores, que responde a los intereses de los productores de AgNP, propuso restringir medidas regulatorias obligatorias y específicas para AgNP, otro grupo de actores, más heterogéneo, identificado con los intereses de trabajadores y consumidores, demandó ampliar la información científico-técnica y exigió medidas de protección a la salud más estrictas. Conclusiones: Entre estas posiciones divergentes, la agencia regulatoria se comportó de forma transparente y receptiva al conducir la consulta pública y modificó substancialmente los límites de exposición a las AgNP propuestos originalmente.Instituto Nacional de Controle de Qualidade em Saúde2019-05-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/125710.22239/2317-269x.01257Health Surveillance under Debate: Society, Science & Technology ; Vol. 7 No. 2 (2019): May; 28-36Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 7 Núm. 2 (2019): Puede; 28-36Vigil Sanit Debate, Rio de Janeiro; v. 7 n. 2 (2019): Maio; 28-362317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZspaenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1257/1009https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1257/1172Copyright (c) 2019 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessFoladori, GuillermoInvernizzi, Noela2023-06-27T15:11:12Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1257Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:11:12Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
Perspectivas e intereses en la construcción de normas de salud ocupacional: el caso de las nanopartículas de plata
title Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
spellingShingle Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
Foladori, Guillermo
Nanosilver
Risks
Recommended Exposure Limits
Regulation
Occupational Safety
nanoprata
riscos
REL
regulação
segurança ocupacional
title_short Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
title_full Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
title_fullStr Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
title_full_unstemmed Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
title_sort Perspectives and interests in the construction of occupational health standards: the case of silver nanoparticles
author Foladori, Guillermo
author_facet Foladori, Guillermo
Invernizzi, Noela
author_role author
author2 Invernizzi, Noela
author2_role author
dc.contributor.author.fl_str_mv Foladori, Guillermo
Invernizzi, Noela
dc.subject.por.fl_str_mv Nanosilver
Risks
Recommended Exposure Limits
Regulation
Occupational Safety
nanoprata
riscos
REL
regulação
segurança ocupacional
topic Nanosilver
Risks
Recommended Exposure Limits
Regulation
Occupational Safety
nanoprata
riscos
REL
regulação
segurança ocupacional
description Introduction: The regulation of chemical substances involves a difficult negotiation between social actors, and requires the articulation between scientific analysis and its conversion into a legal norm. Objective: The article addresses the discussion elicited by a public consultation on a voluntary regulation guide on silver nanoparticles (AgNP) in workplaces. It examines the comments made from 2016 to 2018 by diverse social actors – business representatives, non-governmental organizations (NGO) and independent researchers – to two successive draft versions of a Recommended Exposure Limit (REL) in working environments with AgNP. The REL is a voluntary guideline on permissible exposure limits elaborated by the NIOSH in the United States. A guideline of this kind combines scientific information with its legal adjustment. Method: The methodology used was a content analysis of the comments, structured upon a historical and sociotechnical contextualization of nanotechnologies carried out through literature review and documental analysis. Results: The article shows how different social actors position themselves in the controversy over the risks of nanosilver, revealing a pattern of behavior consistent with their position in the research, production and commercialization of this new nanomaterial. While a group of actors, aligned with the interests of AgNP producers, proposed the restriction of mandatory and AgNP-specific regulation, another group of moreheterogeneous actors, identified with the interests of workers and consumers, demanded for more scientific and technical information and stricter health protection measures. Conclusions: Within these divergent stands, the regulatory agency behaved in a transparent and receptive manner while conducting the public consultation and substantively modified the originally proposed exposure limits to AgNP.
publishDate 2019
dc.date.none.fl_str_mv 2019-05-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1257
10.22239/2317-269x.01257
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1257
identifier_str_mv 10.22239/2317-269x.01257
dc.language.iso.fl_str_mv spa
eng
language spa
eng
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1257/1009
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1257/1172
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; Vol. 7 No. 2 (2019): May; 28-36
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 7 Núm. 2 (2019): Puede; 28-36
Vigil Sanit Debate, Rio de Janeiro; v. 7 n. 2 (2019): Maio; 28-36
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042045325410304